Meaningful products for your patients.
Strong margins for your practice.
Wellness belongs to everyone, plain and simple. It’s likely one of the reasons you got into chiropractic to begin with. So as you know, that means providing drug-free, non-invasive solutions that offer the same physical benefits as more traditional, OTC alternatives without all the side effects. Erchonia offers scientifically proven technology you can trust, with results your patients can feel.
Erchonia laser products provide:
-
Touchless Technology
-
Proven Safe & Effective
-
No Pain, No Downtime, No Risk
Why Erchonia
The only low-level laser company market cleared by the FDA
Erchonia is the only company with low-level lasers that were market cleared by the FDA for use with low back pain, onychomycosis, plantar fasciitis and many other issues. If you’re looking for a solution to treat patients’ needs without surgery or adverse side effects, you’ll find that cold laser therapy is an ideal option for any clinic.
How It Works
Helping expand your practice
With a wide range of applications, our products are an indispensable tool for many healthcare professionals worldwide treating a variety of conditions, such as:
- Low Back Pain
- Neck and Shoulder Pain
- Soft Tissue Damage
- Post Op Pain
- Heel Pain
- Non Invasive Fat Loss
- Onychomycosis
- Plantar Fasciitis
- Acne
Featured Product —
Zerona®-Z6 Laser
OTC Overall Body Circumference Reduction
Zerona-Z6 is a new body-sculpting procedure designed to target fat and contour the body without invasive surgery. Zerona-Z6 unlike other procedures, allows the client to continue their daily activities without interruptions from surgery, pain, wounds or garments. Zerona-Z6 works by utilizing the Erchonia’s patented low-level laser technology to emulsify adipose tissue which then releases into the interstitial space. Our bodies remove the fat from the area and transport the fat from through the lymphatic system creating a slimming effect. The Zerona-Z6 was proven through a double-blind, randomized, multi-site, and placebo-controlled study in which clients averaged a loss of 3.72* inches compared to the placebo group that lost only a half an inch.